We provide iPS cells and related technologies at reasonable cost to companies and research institutions engaged in regenerative medicine research and development.
We are also promoting a collaborative development project with industry partners to develop closed automated cell culture systems aimed at reducing the cost of iPS cell manufacturing.
Our activities include:
・Cell manufacturing, quality evaluation, cell storage management, and operation of cell processing facilities
・Research and development
・Comprehensive support for research, development, and clinical applications
・Education, training, and human resource development
・Information sharing and dissemination through collaborations among academia, industry, and government, as well as international partnerships